Back to search
FDAFDA · Food and drugs·Recall number D-0556-2022

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

Published February 16, 2022 · Recall initiated: January 26, 2022

Summary

FDA records drug Class I recall D-0556-2022, published February 16, 2022 and initiated January 26, 2022. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 35,520 vials; Lot: Lot CPB200013, exp 9/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot

What to do

Voluntary: Firm initiated · Letter

Get an email if POLYMYXIN B has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
POLYMYXIN B
Manufacturer
AuroMedics Pharma LLC
Distributor
Nationwide in the US
UPC
0355150234103
Lot
Lot CPB200013, exp 9/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10 recalled?

Yes. FDA published recall D-0556-2022 on February 16, 2022. Reported hazard: Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: POLYMYXIN B. UPC: 0355150234103.